Advanced search
Publication Cover
Leukemia & Lymphoma Volume 14, 1994 - Issue 1-2
Submit an article Journal homepage
17
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Refractory T-Cell Chronic Lymphocytic Leukemia with Purine Nucleoside Analogues

Thomas E. Witzig Division of Internal Medicine and Hematology, Mayo Clinic and Mayo Foundation, Rochester, MinnesotaUSA; The St Cloud Clinic of Internal Medicine, St Cloud, MinnesotaUSA; The Fond du Lac Clinic, Fond Du Lac, WisconsinUSA
,
John J. Weitz Division of Internal Medicine and Hematology, Mayo Clinic and Mayo Foundation, Rochester, MinnesotaUSA; The St Cloud Clinic of Internal Medicine, St Cloud, MinnesotaUSA; The Fond du Lac Clinic, Fond Du Lac, WisconsinUSA
,
Joel H. Lundberg Division of Internal Medicine and Hematology, Mayo Clinic and Mayo Foundation, Rochester, MinnesotaUSA; The St Cloud Clinic of Internal Medicine, St Cloud, MinnesotaUSA; The Fond du Lac Clinic, Fond Du Lac, WisconsinUSA
&
Ayalew Tefferi Division of Internal Medicine and Hematology, Mayo Clinic and Mayo Foundation, Rochester, MinnesotaUSA; The St Cloud Clinic of Internal Medicine, St Cloud, MinnesotaUSA; The Fond du Lac Clinic, Fond Du Lac, WisconsinUSA
Pages 137-139 | Received 18 Jun 1993, Published online: 01 Jul 2009

References

  • Phyliky R., Li C.-Y., Yam L. T-cell chronic lymphocytic leukemia with morphologic and immunologic characteristics of cytotoxic/suppressor phenotype. Mayo Clin. Proc 1983; 58: 709–720
  • Matutes E., Brito B. V., Swansbury J., Ellis J., Morilla R., Dearden C., Sempere A., Catovsky D. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 1991; 78: 3269–3274
  • Witzig T., Phyliky R., Li C.-Y., Homburger H., Dewald G., Handwerger B. T-cell chronic lymphocytic leukemia with a helper/inducer membrane phenotype: a distinct clinicopathologic subtype with a poor prognosis. Am. J. Hematol. 1986; 21: 139–155
  • Keating M. J., Kantarjian H., Talpaz M., Redman J., McCredie K. B. Fludarabine therapy in chronic lymphocytic leukemia (CLL). Nouv. Rev. Fr. Hematol. 1988; 30: 461–466
  • Piro L. D., Carrera C. J., Beutler B., Carson D. A. 2-Chloro-deoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 1988; 72: 1069–1073
  • Kantarjian Childs H. M.C., O'Brien S., Huh Y., Beran M., Schachner J., Koller C., Keating M. J. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocyte leukemia and the prolympho-cytoid variant of chronic lymphocytic leukemia. Am. J. Med. 1991; 90: 223–228
  • Dearden C., Matutes E., Catovsky D. Deoxycoformycin in the treatment of mature T-cell leukaemias. Br. J. Cancer 1991; 64: 903–906
  • Döhner H., Ho A., Thaler J., Stryckmans P., Sonneveld P., de Witte T., Lechner K., Lauria F., Bodewadt-Radzun S., Witt B., Hunstein W., Zittoun R. Pentostatin in prolymphocyte leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group. J. Nail. Cancer Inst. 1993; 85: 658–662
  • Brito-Babapulle F., Huang D., Lavender P., Gallon D., Catovsky D. Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deox-ycoformycin. Eur. J. Haematol. 1988; 40: 185–187
  • el Agnaf M. R., Ennis K. E., Morris T. C., Robertson J. H., Markey G., Alexander H. D. Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia. Br. J. Haematol. 1986; 63: 93–104
  • Plunkett W., Gandhi V. Cellular metabolism of nucleoside analogs in CLL: implications for drug development. Chronic Lymphocytic Leukemia: Scientific Advances and Clinical Developments, B. Cheson. Marcel Dekker Publishers, New York 1993; 197–220
  • Huang P., Chubb S., Plunkett W. Termination of DNA synthesis by 9-;3-D-arabinofuranosyl-2-fluoroaden-ine. J. Biol. Chem. 1990; 265: 16617–16625
  • Griffig J., Koob R., Blakley R. Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. Cancer Res. 1989; 49: 6923–6928
  • Avery T., Rehg J., Lumm W., Harwood F., Santana V., Blakley R. Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxy-adenosine in drug combinations in mice. Cancer Res. 1989; 49: 4972–4978
  • Brox L., Ng A., Pollock E., Belch A. DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin. Cancer Res. 1984; 44: 934–937

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.